Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 43

Sort by

Sort Order Select

Journal Articles

Impact of Minimal Residual Disease Detected By Multiparameter Flow Cytometry on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients in First Complete Remission

Zoya V. Konova, Elena N. Parovichnikova, MD PhD, Irina V. Galtseva, MD PhD, Nikolay M. Kapranov, Julia O. Davydova, Mikhail Yu. Drokov, MD PhD, Maria V. Nareyko, MD, Natalia N. Popova, MD, Anna A. Dmitrova, MD, Ulyana V. Maslikova, MD, Olga S. Starikova, MD, Ekaterina I. Usikova, MD, Ekaterina D. Mikhaltsova, MD PhD, Olga M. Koroleva, MD, Vera A. Vasilyeva, MD PhD, Tatiana I. Lobanova, MD, Larisa A. Kuzmina, MD PhD, Valeriy G. Savchenko, MD PhD

Blood (2019) 134 (Supplement_1): 4562.

https://doi.org/10.1182/blood-2019-123528

Published: 2019

Journal Articles

Serum Albumin Level, but Not Nutritional Risk Index Predicts Outcomes in Acute Leukemia Patients after Allo-HSCT

Mikhail Yu. Drokov, MD PhD, Natalia N. Popova, MD, Vera A. Vasilyeva, MD PhD, Ekaterina D. Mikhaltsova, MD PhD, Olga M. Koroleva, MD, Zoya V. Konova, Anna A. Dmitrova, MD, Olga S. Starikova, MD, Ulyana V. Maslikova, MD, Maria V. Dovydenko, MD PhD, Ekterina Usikova, Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 1987.

https://doi.org/10.1182/blood-2019-126822

Published: 2019

Journal Articles

Haploidentical Stem Cell Transplantation with TCR Alpha/Beta and CD19 Depletion in Adult Patients with Hematological Malignancies

Maria V. Dovydenko, MD PhD, Elena N. Parovichnikova, MD PhD, Larisa A. Kuzmina, MD PhD, Vera A. Vasilyeva, MD PhD, Mikhail Yu. Drokov, MD PhD, Olga M. Koroleva, MD, Ekaterina D. Mikhaltsova, MD PhD, Natalia N. Popova, MD, Zoya V. Konova, Anna A. Dmitrova, MD, Ulyana V. Maslikova, MD, Olga S. Starikova, MD, Tatiana V. Gaponova, MD PhD, Denis V. Kamelskih, MD, Michael Maschan, MDMSc, Valeriy G. Savchenko, MD PhD

Blood (2019) 134 (Supplement_1): 5648.

https://doi.org/10.1182/blood-2019-131316

Published: 2019

Journal Articles

The Duration of MRD-Negative Status in Multiple Myeloma (MM) Patients after Auto-HSCT Is a Criterion for Prolonged Remission without Maintenance Therapy

Maxim V. Solovev, MD, Larisa P. Mendeleeva, MD PhD Prof, Olga S. Pokrovskaya, MD PhD, Eduard G. Gemdzhian, PhD, Larisa A. Kuzmina, MD PhD, Maiia V. Firsova, Maria V. Nareyko, MD, Irina V. Galtseva, MD PhD, Julia O. Davydova, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 3294.

https://doi.org/10.1182/blood.V130.Suppl_1.3294.3294

Published: 2017

Journal Articles

Chemotherapy Related Neuropsychological Changes in Patients with Hodgkin's Lymphoma and Acute Lymphoblastic Leukemia

Sergei Khrushchev, MS, PhD, Dmitry Vybornykh, MD PhD, Lada Olexenko, Alexandra Nesterova, Alexander Tkhostov, Prof. Dr., Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 5647.

https://doi.org/10.1182/blood.V130.Suppl_1.5647.5647

Published: 2017

Journal Articles

Impact of Post-Transplant High-Dose Cyclophosphamide on Reconstitution in Bone Marrow Recipients

Ekaterina Mikhaltsova, MD, Mikhail Yu. Drokov, MD PhD, Julia O. Davydova, Larisa A. Kuzmina, MD PhD, Natalia Popova, MD, Daria Dubnyak, MD, Vera Vasilyeva, MD, Olga Koroleva, MD, Zoya Konova, MD, Nikolay M. Kapranov, Irina V. Galtseva, MD PhD, Elena N. Parovichnikova, MD PhD, Valery Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 5485.

https://doi.org/10.1182/blood.V130.Suppl_1.5485.5485

Published: 2017

Journal Articles

Histopathological Features of Bone Marrow and Extramedullary Sites in Patients with Multiple Myeloma

Maiia V. Firsova, Larisa P. Mendeleeva, MD PhD Prof, Alla M. Kovrigina, MD PhD, Olga S. Pokrovskaya, MD PhD, Natalia L. Deineko, MD, Maxim V. Solovev, MD, Maria V. Nareyko, MD, Larisa A. Kuzmina, MD PhD, Eduard G. Gemdzhian, PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 5358.

https://doi.org/10.1182/blood.V130.Suppl_1.5358.5358

Published: 2017

Journal Articles

Effective and Ineffective Samples of Mesenchymal Multipotent Stromal Cells Used for Acute Graft-Versus-Host Disease Prophylaxis after Allogeneic Bone Marrow Transplantation Differ in the Expression Level of HLA-DR When Co-Cultured with Activated Lymphocytes

Nataliya Petinati, PhD MD, Nikolay M. Kapranov, Yuliya O Davydova, Alexey Bigildeev, PhD, Natalia Sats, PhD, Irina Shipounova, PhD, Nina Drize, PhD, Irina V. Galtseva, MD PhD, Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 5494.

https://doi.org/10.1182/blood.V130.Suppl_1.5494.5494

Published: 2017

Journal Articles

Intraosseous Administration of Multipotent Mesenchymal Stromal Cells to Patients with Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation

Nataliya Petinati, PhD MD, Natalia Sats, PhD, Nina Drize, PhD, Natalia Risinskaya, Andrey Sudarikov, Maya Firsova, MD PhD, Natalia Popova, MD, Daria Dubnyak, MD, Olga Koroleva, MD, Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 5475.

https://doi.org/10.1182/blood.V130.Suppl_1.5475.5475

Published: 2017

Journal Articles

Blinatumomab + Tyrosine Kinase Inhibitors with No Chemotherapy in BCR-ABL-Positive or IKZF1-Deleted or FLT3-ITD-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia Patients: High Molecular Remission Rate and Toxicity Profile

Andrey N. Sokolov, MD, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Larisa A. Kuzmina, MD PhD, Irina V. Galtseva, Sergei M. Kulikov, PhD, Sergey N. Bondarenko, PhDMD, Julia O. Davidova, Nikolay M. Kapranov, Irina A. Lukyanova, MD, Tatiana I. Lobanova, MD, Ekaterina I. Usikova, MD, Ksenija I. Zarubina, MD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 3884.

https://doi.org/10.1182/blood.V130.Suppl_1.3884.3884

Published: 2017

Journal Articles

Prognostic Impact of Pregnancy on Long-Term Outcome in Acute Leukemias Patients

Vera V. Troitskaya, MD PhD, Elena N. Parovichnikova, MD PhD, Andrey N. Sokolov, MD, Alina Kokhno, MD, PhD, Zalina T. Fidarova, MDPhD, Olga A. Gavrilina, MDPhD, Anna A. Sidorova, MD, Gennadii M. Galstian, Larisa A. Kuzmina, MD PhD, Mikhail Yu. Drokov, MD PhD, Sergei Makhinya, Oleg Latishkevich, Alexandra Zvereva, Anton Olenev, Olga Korobitsyna, Alexandr Korobkin, MD, Elena Kirillova, Sergei M. Kulikov, PhD, Valery G. Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 4665.

https://doi.org/10.1182/blood.V130.Suppl_1.4665.4665

Published: 2017

Journal Articles

Persistence of the Minimal Residual Disease at the End of Induction Is Not a Factor of Poor Prognosis If Imatinib Was Changed to the Dasatinib By Ph+ RALL Protocol in Ph-Positive Acute Lymphoblastic Leukemia Patients

Olga A. Gavrilina, MDPhD, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Larisa A. Kuzmina, MD PhD, Sergey N. Bondarenko, PhDMD, Valery Lapin, Tatiana N. Obukhova, MD PhD, Andrey Sudarikov, PhD, Valery G. Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 2714.

https://doi.org/10.1182/blood.V130.Suppl_1.2714.2714

Published: 2017

Journal Articles

Granzyme B Expression in Conventional CD4+ T-Cells Is Strongly Associated with Increased Relapse Rate during First 6 Months after Allo-HSCT

Mikhail Yu. Drokov, MD PhD, Julia O. Davydova, Larisa A. Kuzmina, MD PhD, Irina V. Galtseva, MD PhD, Nikolay M. Kapranov, Vera Vasilyeva, MD, Daria Dubnyak, MD, Olga Koroleva, MD, Ekaterina Mikhaltsova, MD, Natalia Popova, MD, Zoya Konova, MD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2017) 130 (Supplement 1): 1990.

https://doi.org/10.1182/blood.V130.Suppl_1.1990.1990

Published: 2017

Journal Articles

De-Intensification of the Chemotherapy Did Not Affect the Outcome of Ph-Positive Acute Lymphocytic Leukemia Patients in the Era of Tyrosine Kinase Inhibitors

Olga A. Gavrilina, MDPhD, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Andrey N. Sokolov, MD PhD, Larisa A. Kuzmina, MD PhD, Galina Baskhaeva, MD, Kseniia Zarubina, MD, Valery G Savchenko, MD PhD academician

Blood (2016) 128 (22): 2805.

https://doi.org/10.1182/blood.V128.22.2805.2805

Published: 2016

Journal Articles

Immune Privileged Features of Multipotent Mesenchymal Stromal Cells Are Lost after Co-Cultivation with Allogeneic Lymphocytes in Vitro

Nikolay M Kapranov, Yuliya O Davydova, Nataliya Petinati, PhD, Maria V Bakshinskayte, Irina V Galtseva, Nina I. Drize, PhD, Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valeriy G Savchenko, PhD MD

Blood (2016) 128 (22): 5722.

https://doi.org/10.1182/blood.V128.22.5722.5722

Published: 2016

Journal Articles

Maintenance Therapy after Autologous Haematopoietic Stem Cell Transplantation (auto-HSCT) in Multiple Myeloma Patients with and without Minimal Residual Disease (MRD)

Maxim V. Solovev, MD PhD, Larisa P. Mendeleeva, MD PhD Prof, Olga S. Pokrovskaya, MD PhD, Eduard G. Gemdzhian, PhD, Larisa A. Kuzmina, MD PhD, Maya Firsova, MD, Irina Galtseva, MD PhD, Julia Davydova, MD, Valeri G. Savchenko, MD PhD Prof.

Blood (2016) 128 (22): 2260.

https://doi.org/10.1182/blood.V128.22.2260.2260

Published: 2016

Journal Articles

Granzyme B Expression in T-Regulatory Cells Is a Strong Predictor of Acute Graft-Versus-Host Disease after Day +30 in Patients with "Classic" Immunosuppression after Allo-HSCT

Mikhail Yu. Drokov, MD PhD, Elena N. Parovichnikova, MD PhD, Julia Davydova, MD, Larisa A. Kuzmina, MD PhD, Irina V Galtseva, Nikolay M Kapranov, Vera Vasilieva, Darya Dubnyak, Olga Koroleva, Ekaterina Mikhalcova, Natalia Popova, Valery G Savchenko, MD PhD academician

Blood (2016) 128 (22): 2238.

https://doi.org/10.1182/blood.V128.22.2238.2238

Published: 2016

Journal Articles

Pregnancy Is a Poor Prognostic Factor for AML Outcome

Vera V. Troitskaya, MD PhD, Elena N. Parovichnikova, MD PhD, Andrey N. Sokolov, MD PhD, Alina Kokhno, MD, PhD, Zalina T. Fidarova, Anna A. Sidorova, MD, Olga A. Gavrilina, MD PhD, Gennadii M. Galstian, MD PhD, Aleksei Bazhenov, MD, Larisa A. Kuzmina, MD PhD, Mikhail Yu. Drokov, MD PhD, Sergei Makhinya, Oleg Latishkevich, Alexandra Zvereva, Valery G Savchenko, MD PhD academician

Blood (2016) 128 (22): 5171.

https://doi.org/10.1182/blood.V128.22.5171.5171

Published: 2016

Journal Articles

No Differences in the Treatment Outcome in T-Cell Acute Lymphoblastic Leukemia/Lymphoma Regarding the Initial Bone Marrow Blasts Count: Results of the Russian Acute Lymphoblastic Leukemia (RALL) Study Group

Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Andrey N. Sokolov, MD PhD, Larisa A. Kuzmina, MD PhD, Sergey Bondarenko, MD PhD, Olga Baranova, Zalina Akhmerzaeva, Mikhail Rusinov, Sergei M Kulikov, PhD, Valery G Savchenko, MD PhD academician

Blood (2016) 128 (22): 5149.

https://doi.org/10.1182/blood.V128.22.5149.5149

Published: 2016

Journal Articles

Modification of Gene Expression in Mesenchymal Stromal Cells of the Leukemia Patients during Chemotherapy

Tamara Sorokina, MD, Irina Shipounova, PhD, Alexey Bigildeev, PhD, Nina I. Drize, PhD, Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valery G Savchenko, MD PhD academician

Blood (2016) 128 (22): 5065.

https://doi.org/10.1182/blood.V128.22.5065.5065

Published: 2016

NARROW

Impact of Minimal Residual Disease Detected By Multiparameter Flow Cytometry on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients in First Complete Remission

Serum Albumin Level, but Not Nutritional Risk Index Predicts Outcomes in Acute Leukemia Patients after Allo-HSCT

Haploidentical Stem Cell Transplantation with TCR Alpha/Beta and CD19 Depletion in Adult Patients with Hematological Malignancies

The Duration of MRD-Negative Status in Multiple Myeloma (MM) Patients after Auto-HSCT Is a Criterion for Prolonged Remission without Maintenance Therapy

Chemotherapy Related Neuropsychological Changes in Patients with Hodgkin's Lymphoma and Acute Lymphoblastic Leukemia

Impact of Post-Transplant High-Dose Cyclophosphamide on Reconstitution in Bone Marrow Recipients

Histopathological Features of Bone Marrow and Extramedullary Sites in Patients with Multiple Myeloma

Effective and Ineffective Samples of Mesenchymal Multipotent Stromal Cells Used for Acute Graft-Versus-Host Disease Prophylaxis after Allogeneic Bone Marrow Transplantation Differ in the Expression Level of HLA-DR When Co-Cultured with Activated Lymphocytes

Intraosseous Administration of Multipotent Mesenchymal Stromal Cells to Patients with Graft Failure after Allogeneic Hematopoietic Stem Cell Transplantation

Blinatumomab + Tyrosine Kinase Inhibitors with No Chemotherapy in BCR-ABL-Positive or IKZF1-Deleted or FLT3-ITD-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia Patients: High Molecular Remission Rate and Toxicity Profile

Prognostic Impact of Pregnancy on Long-Term Outcome in Acute Leukemias Patients

Persistence of the Minimal Residual Disease at the End of Induction Is Not a Factor of Poor Prognosis If Imatinib Was Changed to the Dasatinib By Ph+ RALL Protocol in Ph-Positive Acute Lymphoblastic Leukemia Patients

Granzyme B Expression in Conventional CD4+ T-Cells Is Strongly Associated with Increased Relapse Rate during First 6 Months after Allo-HSCT

De-Intensification of the Chemotherapy Did Not Affect the Outcome of Ph-Positive Acute Lymphocytic Leukemia Patients in the Era of Tyrosine Kinase Inhibitors

Immune Privileged Features of Multipotent Mesenchymal Stromal Cells Are Lost after Co-Cultivation with Allogeneic Lymphocytes in Vitro

Maintenance Therapy after Autologous Haematopoietic Stem Cell Transplantation (auto-HSCT) in Multiple Myeloma Patients with and without Minimal Residual Disease (MRD)

Granzyme B Expression in T-Regulatory Cells Is a Strong Predictor of Acute Graft-Versus-Host Disease after Day +30 in Patients with "Classic" Immunosuppression after Allo-HSCT

Pregnancy Is a Poor Prognostic Factor for AML Outcome

No Differences in the Treatment Outcome in T-Cell Acute Lymphoblastic Leukemia/Lymphoma Regarding the Initial Bone Marrow Blasts Count: Results of the Russian Acute Lymphoblastic Leukemia (RALL) Study Group

Modification of Gene Expression in Mesenchymal Stromal Cells of the Leukemia Patients during Chemotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only